https://www.taxtmi.com/news?id=64694 Orvakal is developing as a pharmaceutical manufacturing hub after Virupaksha Organics received approval for over 100 acres in the IP Guttapadu Cluster to build an API and organic chemicals facility with a Rs 1,225 crore investment and about 1,500 direct jobs, while Sigachi Industries is expanding excipient production; both expansions were formalised at the CII Partnership Summit and are driving regional industrial concentration and employment. en-us Mon, 15 Dec 2025 13:31:03 +0530 Mon, 15 Dec 2025 13:31:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=64694 Orvakal is developing as a pharmaceutical manufacturing hub after Virupaksha Organics received approval for over 100 acres in the IP Guttapadu Cluster to build an API and organic chemicals facility with a Rs 1,225 crore investment and about 1,500 direct jobs, while Sigachi Industries is expanding excipient production; both expansions were formalised at the CII Partnership Summit and are driving regional industrial concentration and employment. News - Mon, 15 Dec 2025 13:31:03 +0530 https://www.taxtmi.com/news?id=64694